[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  AFV GLOBAL [@afvglobal](/creator/twitter/afvglobal) on x XXX followers Created: 2025-07-16 10:55:00 UTC ๐ J&J Beats Q2 Estimates, Hikes 2025 Sales Forecast โ ๐ Darzalex Shines: Flagship cancer drug pulled in $3.54B in Q2 sales, beating estimates โ ๐ฅ MedTech Momentum: Medical devices unit up 6.1%, totaling $8.5B in revenue โ ๐ EPS Surprise: Adjusted EPS at $2.77, topping Wall Street's $XXXX forecast โ ๐ต Revenue Beat: Q2 revenue hit $23.74B vs. expected $22.84B โ ๐ผ Full-Year Boost: FY revenue now guided at $93.2โ$93.6B, up $2B from April outlook โ ๐ธ Tariff Relief: Estimated impact cut from $400M to $200M after U.S.-China tariff pause โ ๐ฌ CFO Wolk: โWe absorbed the tariffs and still raised EPS guidance by XX cents.โ โ ๐งพ 2025 EPS Raised: Now expecting $10.80โ$10.90, up from $10.50โ$10.70 #JNJ #Earnings #HealthcareStocks #Pharma #Darzalex #MedTech #Tariffs #WallStreet #Q2Earnings #USChina $JNJ XX engagements  **Related Topics** [$2284b](/topic/$2284b) [$2374b](/topic/$2374b) [eps](/topic/eps) [$85b](/topic/$85b) [momentum](/topic/momentum) [medtech](/topic/medtech) [$354b](/topic/$354b) [sales forecast](/topic/sales-forecast) [Post Link](https://x.com/afvglobal/status/1945437002171613460)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
AFV GLOBAL @afvglobal on x XXX followers
Created: 2025-07-16 10:55:00 UTC
๐ J&J Beats Q2 Estimates, Hikes 2025 Sales Forecast
โ ๐ Darzalex Shines: Flagship cancer drug pulled in $3.54B in Q2 sales, beating estimates โ ๐ฅ MedTech Momentum: Medical devices unit up 6.1%, totaling $8.5B in revenue โ ๐ EPS Surprise: Adjusted EPS at $2.77, topping Wall Street's $XXXX forecast โ ๐ต Revenue Beat: Q2 revenue hit $23.74B vs. expected $22.84B โ ๐ผ Full-Year Boost: FY revenue now guided at $93.2โ$93.6B, up $2B from April outlook โ ๐ธ Tariff Relief: Estimated impact cut from $400M to $200M after U.S.-China tariff pause โ ๐ฌ CFO Wolk: โWe absorbed the tariffs and still raised EPS guidance by XX cents.โ โ ๐งพ 2025 EPS Raised: Now expecting $10.80โ$10.90, up from $10.50โ$10.70 #JNJ #Earnings #HealthcareStocks #Pharma #Darzalex #MedTech #Tariffs #WallStreet #Q2Earnings #USChina $JNJ
XX engagements
Related Topics $2284b $2374b eps $85b momentum medtech $354b sales forecast
/post/tweet::1945437002171613460